The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Physician volume and discontinuation of rituximab during lymphoma treatment.
 
Scott F. Huntington
Honoraria - Pharmacyclics
Consulting or Advisory Role - Celgene; Janssen
Travel, Accommodations, Expenses - Celgene
 
Jessica B. Long
No Relationships to Disclose
 
Jessica R. Hoag
No Relationships to Disclose
 
Rong Wang
No Relationships to Disclose
 
Amer M Zeidan
Honoraria - ARIAD; Celgene; Gilead Sciences; Incyte; Pfizer
Consulting or Advisory Role - ARIAD; Celgene; Gilead Sciences; Incyte; Pfizer
 
Smith Giri
No Relationships to Disclose
 
Steven Gore
Honoraria - Celgene
Research Funding - Boehringer Ingelheim; Celgene
Travel, Accommodations, Expenses - Celgene
 
Xiaomei Ma
Consulting or Advisory Role - Celgene; Incyte
 
Cary Philip Gross
Research Funding - 21st Century Oncology; Johnson & Johnson; Medtronic; Pfizer
 
Amy J. Davidoff
Honoraria - Celgene (I)
Consulting or Advisory Role - Celgene (I)
Research Funding - Boehringer Ingelheim (I); Celgene (I)
Travel, Accommodations, Expenses - Celgene (I)
Other Relationship - PhRMA Foundation